Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT05386056 · UNKNOWN
Trial details
- NCT number
- NCT05386056
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-10-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.